Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.0950
-0.0050 (-5.00%)
Aug 28, 2026, 3:57 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 32.71 million as of August 28, 2026. Its market cap has increased by 14.15% in one year.
Market Cap
32.71M
Enterprise Value
162.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 32.71M, an increase of 42.58%. That is a compound annual growth rate of 1.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 32.71M | 13.74% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 41.54M |
| Sona Nanotech | 41.14M |
| Defence Therapeutics | 39.41M |
| Telescope Innovations | 39.20M |
| The More Life Company | 36.56M |
| Thiogenesis Therapeutics | 35.69M |
| Quantum BioPharma | 35.34M |
| Onco-Innovations | 34.16M |